The French Cochlear Implant Registry (EPIIC): General indicators.

Autor: Gauvrit F; Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France., Risoud M; Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France., Aubry K; CHU de Limoges, Limoges, France., Bordure P; CHU de Nantes, Nantes, France., Bozorg-Grayeli A; CHU de Dijon, Dijon, France., Deguine O; CHU de Toulouse, Toulouse, France., Eyermann C; CHU de Strasbourg, Strasbourg, France., Franco-Vidal V; CHU de Bordeaux, Bordeaux, France., Godey B; CHU de Rennes, Rennes, France., Guevara N; CHU de Nice, Nice, France., Karkas A; CHU de St Etienne, Saint-Etienne, France., Klopp N; CHU d'Amiens, Amiens, France., Labrousse M; CHU de Reims, Reims, France., Lebreton JP; CHU de Poitiers, Poitiers, France., Lerosey Y; CHU de Rouen, Rouen, France., Lescanne E; CHU de Tours, Tours, France., Loundon N; Hôpital Necker, Paris, France., Marianowski R; CHU de Brest, Brest, France., Merklen F; CHU de Montpellier, Montpellier, France., Mezouaghi K; CH de La Réunion, La Réunion, France., Mom T; CHU de Clermont-Ferrand, Clermont-Ferrand, France., Moreau S; CHU de Caen, Caen, France., Mosnier I; Hôpital Pitié-Salpétrière, Paris, France., Noël-Petroff N; Hôpital Robert-Debré, Paris, France., Parietti C; CHU de Nancy, Nancy, France., Piller P; CHT de Nouméa - Nouvelle-Calédonie, France., Poncet C; Hôpital Rothschild, Paris, France., Radafy E; CH du Lamentin, Martinique, France., Roman S; CHU de Marseille, Marseille, France., Roux-Vaillard S; CHU d'Angers, Angers, France., Schmerber S; CHU de Grenoble, La Tronche, France., Tavernier L; CHU de Besançon, Besançon, France., Truy E; CHU de Lyon, Lyon, France., Vincent C; Service d'Otologie et d'Otoneurologie, CHU de Lille, rue Emile-Laine, 59037 Lille, France. Electronic address: otologie@chru-lille.fr.
Jazyk: angličtina
Zdroj: European annals of otorhinolaryngology, head and neck diseases [Eur Ann Otorhinolaryngol Head Neck Dis] 2020 Sep; Vol. 137 Suppl 1, pp. S5-S9. Date of Electronic Publication: 2020 Sep 03.
DOI: 10.1016/j.anorl.2020.07.009
Abstrakt: Cochlear and brainstem implants have been included on the list of reimbursable products (LPPR) in France since March of 2009. The implants were initially inscribed for 5 years, after which an application for renewal with the French National Commission for the Evaluation of Medical Devices and Health Technologies (Commission Nationale d'évaluation des dispositifs médicaux et des technologies de santé - CNEDiMTS) was required [Haute Autorité de santé, 2009]. Upon registration to the list of reimbursable products, the companies and the reference centers for cochlear and brainstem implants were asked to set up a post-registration registry called EPIIC. This article reports the evolution in the EPIIC registry of the general indicators for 5051 patients over the five years from 2012-2016.
(Copyright © 2020. Published by Elsevier Masson SAS.)
Databáze: MEDLINE
Externí odkaz: